Harrington Investments, Inc Gilead Sciences, Inc. Put Options Transaction History
Harrington Investments, Inc
- $173 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GILD
# of Institutions
2,272Shares Held
996MCall Options Held
9.63MPut Options Held
9.92M-
Black Rock Inc. New York, NY121MShares$12.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$11.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$5.97 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.48 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.37 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $126B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...